Fatemeh Karami
Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
[ 1 ] - Evaluation of a new 99mTc-Bombesin analog in differentiation of malignant from benign breast tumors
Introduction: The gastrin releasing peptide (GRP) receptor is over expressed in a variety of common human tumors. Radiolabeled bombesin analogues have exhibited high binding affinity for these receptors. The aim of this study was to assess the value of a new 99mTc-bombesin analog in the differentiation of malignant from benign breast tumors. Methods: 99mTc-bombesin scans ...
نویسندگان همکار